Vitamin D Status and Sars-cov-2 Infection in a Cohort of Renal Transplanted Patients
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico Milano, Milano, Italy
Meeting: 2022 American Transplant Congress
Abstract number: 1723
Keywords: COVID-19, Infection, Inflammation, Kidney transplantation
Topic: Clinical Science » Kidney » 46 - Kidney Complications: Non-Immune Mediated Late Graft Failure
Session Information
Session Name: Kidney Complications: Non-Immune Mediated Late Graft Failure
Session Type: Poster Abstract
Date: Tuesday, June 7, 2022
Session Time: 7:00pm-8:00pm
Presentation Time: 7:00pm-8:00pm
Location: Hynes Halls C & D
*Purpose: Immunomodulatory and anti-inflammatory properties have been hypothesized for native vitamin D (nVD). Very little is reported about nVD and risk of Sars-CoV-2 infection (COV) in renal transplant (RTx). In a cohort of renal transplanted patients (RTxp) we retrospectively evaluated: a) nVD status in patients with (COV+) and without (COV-) COV infection; b) the impact of nVD status on severity of COV.
*Methods: The study includes 61 COV+ in whom nVD status was available in the year before the infection, and 122 COV- matched 1:2 for age (53[45-64]years), gender (M=60.7%), RTx vintage (7[2-15]years), presence of diabetes (18%), arterial hypertension (85%) and cardiac symptomatic disease (3%). Renal function, 24-h proteinuria, mineral metabolism (MM) parameters were evaluated at 1, 6 and 12 months before COV whereas nVD status was considered as the mean 25-OH-VD levels at the same timepoints. Severity of COV was based on the need for hospitalization (HOSP+: 27/61, 44.3%) and death (D+: 6/61, 9.8%).
*Results: a) nVD levels were significantly lower in COV+ than in COV- (19[12-26] ng/mL and 23[16-30] ng/mL, respectively, p=0.01). No differences in the other biochemical parameters were found. The COV discriminative power of nVD status was evaluated by ROC curve (AUC 0.61, 95% CI 0.54-0.68, p=0.01), with a value of 25-OHVD 23.9 ng/mL showing the best discriminative power (sensibility 72%, specificity 47%).b) nVD levels showed a trend towards lower values in HOSP+COV+ than HOSP-COV+ (17[8-25] ng/mL vs 20[14-26] ng/mL) and in D+COV+ than D-COV+ (13[6-23] ng/mL vs 20[13-26] ng/mL), although these differences did not reach the statistical significance (p=0.1 and p=0.2, respectively).
*Conclusions: With the limitations of the retrospective nature of the study and the small sample size, our data report that:COV+ showed lower nVD levels in the year preceding the infection compared to controls with similar main demographic features and comorbid conditionsNo differences were found in renal function, proteinuria, and other MM parameters between the two groupsNo association was found between nVD levels in the year preceding the infection and COV severity.
To cite this abstract in AMA style:
Regalia A, Alfieri CM, Campise M, Cresseri D, Gandolfo M, Messa P, Castellano G. Vitamin D Status and Sars-cov-2 Infection in a Cohort of Renal Transplanted Patients [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/vitamin-d-status-and-sars-cov-2-infection-in-a-cohort-of-renal-transplanted-patients/. Accessed November 21, 2024.« Back to 2022 American Transplant Congress